Business Wire

TENNIS/NAOMI-OSAKA

11.1.2024 05:01:33 CET | Business Wire | Press release

Share
Yonex Announced as Official Partner for the 2024 Australian Open; Marking 9 Consecutive Years and Stringing 57,000 Racquets

Yonex Co., Ltd., the leading sports equipment company from Japan, is proud to announce that it will serve as the Official Stringer for the 9th year at the 2024 Australian Open.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240110185700/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

The Yonex Stringing Team at the Australian Open

This agreement is the result of the Yonex team’s proven technical expertise in racquet stringing, and the high-performance, proprietary stringing machines that they use. One of the most prestigious tennis tournaments, the Australian Open appointment comes at the request of both athletes and the tournament organizers.

Over the nine Australian Opens that Yonex has supported including this year, it expects to use a total of approximately 700 km of string for 57,000 racquets.* This is almost the same distance as many will travel from Sydney to Melbourne to watch the event!

* Approximately 12 meters of string is necessary to prepare one racquet.

The importance of the stringing

The quality of the stringing can make or break an athlete’s game. Factors such as temperature, humidity, and even the playstyle of your opponent can change the way that the ball bounces off a racquet. For this reason, players constantly look to change their strings to maximize their competitiveness – even from one match to the next.

Being able to deliver the ideal racquet experience requested by the athlete comes down to the skill of the stringers. The Yonex 2024 stringing team consists of 20 stringers from 14 countries, and this team is supported by the high-performance proprietary machines “PRECISION 9.0” that excel in precision stringing.

Naomi Osaka to return to the AO

The twice AO champion Naomi Osaka (JPN) from Team Yonex, who will return to a grand slam tournament after a break for the 2024 Australian Open, is one example of an athlete that relies on the quality of her strings, and a specific way that her racquets are strung, to maximize her performance on the court.

For her return, she has tested different types of strings. "I chose the combination of Yonex’s POLYTOUR STRIKE to bring power and POLYTOUR PRO for a softer feel”. It realizes long-lasting tension and excellent control, so I can stay on the offensive even in tough matches,” Osaka said. Osaka also typically takes one racquet with a slightly higher tension into matches, just to be prepared.

She relies on the Yonex team to have all of this ready for her. “I trust the Yonex team to string quickly and exactly how I want it,” Osaka said.

Interviews with the Yonex Stringing Team at the Australian Open are also available.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240110185700/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements15.6.2026 12:00:00 CEST | Press release

Sinovac Biotech Ltd. (Nasdaq: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated June 10, 2026 (the "Notification Letter"), from Hearing Advisor of The Nasdaq Stock Market LLC., indicating that the Company has regained compliance with Listing Rule 5250(c)(1) and that the Company is therefore in compliance with the Nasdaq Global Market's listing requirements. As noted in the Hearing Panel's May 20, 2026 compliance determination, the Company remains under a Mandatory Panel Monitor pursuant to Listing Rule 5815(d)(4)(B) until May 20, 2027. The Company filed its annual report on Form 20-F for the year ended December 31, 2025 on June 5, 2026. The Notification Letter also stated that the hearing before the Hearings Panel, applied for by the Company, had accordingly been canceled. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission

KRM22 partners with Sigma AI to enhance market surveillance and risk intelligence capabilities15.6.2026 12:00:00 CEST | Press release

KRM22, the technology and software investment company focused on risk management solutions for capital markets, today announced a strategic partnership with Sigma AI, a leading provider of AI-driven financial insights, to integrate advanced news sentiment analytics into its risk management application suite. The integration marks a significant enhancement to KRM22’s capabilities, enabling clients to incorporate real-time market sentiment insights derived from global news sources directly into their risk frameworks. By leveraging Sigma AI’s proprietary natural language processing and machine learning models, KRM22 will help firms better identify emerging risks, anticipate market-moving events, and make more informed trading and compliance decisions. Advancing risk management through AI-driven sentiment analysis As part of the first phase of the collaboration, KRM22 will embed Sigma AI’s news sentiment engine within its application suite. This will provide users with actionable intellige

HUI (HUI:VSE) Merges Traditional and Crypto Finance: Commences Continuous Trading in Vienna With Leading Market Maker and Announces Impending Token Listing on Major Global Exchange15.6.2026 11:15:00 CEST | Press release

The first SaaS SuperApp for startups and VCs capitalizes on a $25M round a from Nimbus Capital and a +15% stock surge, unveiling a v3/v4 roadmap that bridges public equity with digital asset liquidity. HUI S.p.A., the pioneering vertical SuperApp and SaaS company dedicated to the global Venture Capital and startup ecosystem listed on the Vienna Stock Exchange, today released its global product strategy, marking an unprecedented convergence between traditional regulated markets and decentralized finance. Driven by a +15% stock surge and the consolidation of its $25 million round a equity commitment fully subscribed by global institutional fund Nimbus Capital, the company announced its upcoming transition to continuous trading on the Vienna market in partnership with a leading European market maker, alongside the activation of the initial PUT options tied to the round. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2026061293689

Syngenta Signs MoU to Be Strategic Partner in India’s First Open-Data Agricultural Ecosystem Annam.AI15.6.2026 09:35:00 CEST | Press release

Agricultural innovation leader to contribute with agronomic expertise in building accurate crop health, pest forecasting and heat stress models India’s agriculture sector is a global powerhouse, uniquely characterized by its massive scale, vast arable land, diverse agro-climatic zones and rich biodiversity. These strengths have propelled the country to become one of the world’s leading producers of crops such as rice and wheat. However, farmers in the country face significant challenges – from erratic monsoons, severe droughts and unseasonal rains compounded by El Nino, to pests and diseases that destroy an estimated 30 percent of crops annually. More than 80 percent of India’s estimated 150 million farming households are composed of smallholder farmers who operate on less than two hectares of land. This limits economies of scale, sets obstacles to the wider adoption of advanced technologies and could widen a systemic gap between large commercial agricultural operations and the bulk of

Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry15.6.2026 09:00:00 CEST | Press release

The combination unites Pelago Bioscience’s industry-leading and proprietary cellular target engagement capabilities with RG Discovery’s deep medicinal chemistry and custom synthesis expertise - enabling customers to advance drug discovery programs across the full design-make-test-analyze-(DMTA) cycle with a single specialist partner. Pelago Bioscience, a specialist drug discovery focused contract research organization (CRO), known for its industry-leading cell-based target engagement assays, is pleased to announce the acquisition of RG Discovery, and thereby adding deep expertise in medicinal chemistry, custom synthesis, and integrated drug discovery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615340933/en/ Michael Dabrowski, Chief Executive Officer of Pelago Bioscience By combining Pelago Bioscience's biology-focused capabilities with RG Discovery's chemistry expertise, the enlarged platform will enable drug discover

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye